
Kappa Light Chains - Free, Serum








The Kappa Light Chains - Free, Serum test measures the level of free kappa light chains in the blood. Light chains are small protein components of antibodies produced by plasma cells in the bone marrow. Elevated levels may indicate abnormal plasma cell activity, making this test useful for diagnosing and monitoring conditions such as multiple myeloma, monoclonal gammopathy, amyloidosis, and other plasma cell disorders.













Understanding Kappa Light Chains - Free, Serum
Antibodies are proteins made by plasma cells to help the body fight infections. Each antibody contains two types of protein parts called heavy chains and light chains. Light chains are of two types: kappa and lambda. During normal antibody production, a small amount of extra light chains enters the bloodstream as free light chains. While low levels are normal, abnormal levels may be associated with plasma cell disorders, immune system conditions, or kidney problems.
The Kappa Light Chains - Free, Serum test specifically measures the level of free kappa light chains in the blood. Elevated levels may occur when abnormal plasma cells produce excessive amounts of kappa light chains, as seen in conditions such as multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), light chain myeloma, Waldenström macroglobulinemia, and AL amyloidosis. These abnormal proteins may accumulate in the body and affect organs such as the kidneys, bones, nerves, or heart.
The test is commonly performed along with lambda light chains and the kappa/lambda free light chain ratio. Evaluating both light chains together helps doctors determine whether abnormal results are caused by a plasma cell disorder, such as multiple myeloma, or are related to other conditions such as infection, inflammation, or kidney dysfunction.
Doctors may recommend the Kappa Light Chains - Free, Serum for individuals with symptoms such as persistent bone pain, unexplained fractures, fatigue, anemia, recurrent infections, weight loss, numbness, kidney problems, or abnormal protein findings on blood or urine tests. It is also useful for monitoring treatment response and disease progression in individuals already diagnosed with plasma cell disorders.
Usually, no special preparation is required before undergoing the Kappa Light Chains - Free, Serum test. However, it is important to inform your doctor about any medications, supplements, or medical conditions you may have, as these factors could potentially affect the test results.
Lab test results may vary across different laboratories and due to various factors, such as age and underlying illness, among others. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate at home based solely on these results. Always consult a doctor for a proper understanding of the test results.
What does Kappa Light Chains - Free, Serum measure?
The Kappa Light Chains - Free, Serum measures the concentration of free kappa light chains circulating in the blood. Free kappa light chains are protein fragments produced by plasma cells during antibody formation. Elevated levels may occur when abnormal plasma cells produce excessive amounts of kappa light chains, as seen in conditions such as multiple myeloma, MGUS, and AL amyloidosis. High free kappa light chain levels may indicate plasma cell proliferation, immune activation, or reduced kidney clearance. Low levels are less common and are usually not clinically significant on their own. However, abnormal results alone do not confirm a specific diagnosis and should always be interpreted together with symptoms, medical history, imaging studies, and additional laboratory investigations.





FAQs related to Kappa Light Chains - Free, Serum
- Free light chains (Blood) [Internet].Rochester, NY: University of Rochester Medical Center; [Accessed 28 May 2026]. Available from:
- Tosi P, Tomassetti S, Merli A, Polli V. Serum free light-chain assay for the detection and monitoring of multiple myeloma and related conditions. Ther Adv Hematol. 2013 Feb;4(1):37-41. [Accessed 28 May 2026]. Available from:
- Arneth B, Kraus J. The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis. Medicina (Kaunas). 2022 Oct 24;58(11):1512. [Accessed 28 May 2026]. Available from:
- Gudowska-Sawczuk M, Mroczko B. Free Light Chains κ and λ as New Biomarkers of Selected Diseases. Int J Mol Sci. 2023 May 31;24(11):9531. [Accessed 28 May 2026]. Available from:
- Silva C, Costa A, Paiva D, Freitas S, Alves G, Cotter J. Light-Chain Multiple Myeloma: A Diagnostic Challenge. Cureus. 2021 Oct 29;13(10):e19131. [Accessed 28 May 2026]. Available from:
- Plasma Cell Dyscrasia [Internet]. ScienceDirect; [Accessed 28 May 2026]. Available from:
Other tests
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)














